Document is current
Any future updates will be listed below
-
Authors
Iliopoulos, Konstantinos
Koufaki, Panagiota
Tsilikas, Stavros
Avramidis, Kyriakos
Tsagkalis, Antonios
Mavragani, Clio
Zintzaras, Elias
-
Funding
Funding for this research was provided by:
Win Medica SA
- License Information
-
More Information
Article History
Received: 8 September 2022
Accepted: 1 June 2023
First Online: 10 June 2023
Declarations
:
: Written informed consent was obtained before recruitment, and ethics approval for the study was granted by the Greek National Ethics Committee and the National Organization for Medicines. This trial was registered with EudraCT No: 2017–004530-29.This trial was performed in accordance with the ethical standards of the Declaration of Helsinki. The participants were blinded to the treatment they received.
: Not applicable.
: EZ is contracted in the Clinical Research Organization that monitored the study. PK is an employee of the company that sponsored the study. KI, ST, KA, AT and CM were investigators in the hospitals where the study was conducted.
